ALKERMES | Capitalizzazione Di Mercato



Market Capitalization Cambiamento Data
AbbVie USD 314.02B 34.8B 2024-12
Acadia Pharmaceuticals USD 3.05B 502M 2024-12
ALKERMES USD 4.65B 123M 2024-12
Amgen USD 140.1B 33.03B 2024-12
Biogen USD 22.28B 5.95B 2024-12
BioMarin Pharmaceutical USD 12.53B 867M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Eli Lilly USD 732.87B 109.15B 2024-12
Gilead Sciences USD 115.12B 10.74B 2024-12
Intra Cellular Therapies USD 8.87B 1.14B 2024-12
Ionis Pharmaceuticals USD 5.52B 791M 2024-12
J&J USD 348.19B 41.93B 2024-12
Merck USD 251.65B 36.21B 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Otsuka Holdings JPY 4.75T 238.43B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
Vertex Pharmaceuticals USD 103.71B 16.33B 2024-12



ALKERMES Capitalizzazione Di Mercato - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.